Drugs / HPV 9-valent vaccine
last change Mar 2025 re-read 2 minutes ago

HPV 9-valent vaccine

Vaccine

Developed for
cervical carcinoma
Investigated by
Northern Jiangsu People's Hospital

Trials 1 · a red edge is where a trial was stopped

202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT06882447 Mar 2025 → Dec 2027 expected cervical carcinoma Northern Jiangsu People's Hospital Not yet recruiting No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as HPV 9-valent vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT06882447
Modality Vaccine “HPV 9-valent vaccineNCT06882447